The prognostic value of neurofilament light chain in serum

Interest in the use of fluid biomarkers for monitoring disease course in multiple sclerosis is growing. Neurofilaments are structural proteins, and neurofilament light chain (NfL) is released after neuroaxonal injury.1 NfL can be measured in blood by ultrasensitive assays, with good correlation between blood and CSF levels.1,2